Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion
- PMID: 39171208
- PMCID: PMC11338662
- DOI: 10.1155/2024/4937501
Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion
Abstract
Inflammatory myofibroblastic tumor (IMT) is a rare soft tissue tumor primarily occurring in the abdominopelvic region of young patients, and it is characterized by spindle-shaped myofibroblasts, or fibroblasts surrounded by inflammatory infiltrate. Herein, we report a case of a 24-year-old male with a firm submucosal mass in the anterior right vocal fold diagnosed as an IMT that recurred 14 months later. The tumor demonstrated a novel THBS1::ALK fusion containing Exons 1-7 of the thrombospondin 1 (THBS1) gene fused to Exon 19 of the anaplastic lymphoma kinase (ALK) gene via next-generation sequencing with the NextSeq sequencer. The fusion of THBS1 to ALK potentially results in increased expression and constitutive activation of the ALK kinase domain. These findings not only broaden the repertoire of known ALK fusion partners implicated in tumorigenesis but also provide a novel avenue for investigating the etiology of recurrent IMT by considering this fusion event as a causal factor. To our knowledge, this is the second case of IMT of the larynx with this novel mutation reported in the literature and the first such case with a detailed description of this specific fusion and clinical recurrence.
Keywords: ALK fusion; IMT; Inflammatory myofibroblastic tumor; THBS1; larynx.
Copyright © 2024 Namra Ajmal et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.Am J Surg Pathol. 2017 Jun;41(6):773-780. doi: 10.1097/PAS.0000000000000801. Am J Surg Pathol. 2017. PMID: 28490045
-
A Novel ALK-THBS1 Fusion in a Laryngeal Inflammatory Myofibroblastic Tumour: A Case Report and Literature Review.Head Neck Pathol. 2020 Jun;14(2):454-458. doi: 10.1007/s12105-019-01061-x. Epub 2019 Jul 31. Head Neck Pathol. 2020. PMID: 31368077 Free PMC article. Review.
-
Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.Diagn Pathol. 2016 Nov 15;11(1):132. doi: 10.1186/s13000-016-0586-z. Diagn Pathol. 2016. PMID: 27846861 Free PMC article.
-
Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.Am J Surg Pathol. 2021 Dec 1;45(12):1707-1719. doi: 10.1097/PAS.0000000000001735. Am J Surg Pathol. 2021. PMID: 34001695
-
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.J Pathol. 2017 Feb;241(3):316-323. doi: 10.1002/path.4836. Epub 2016 Dec 15. J Pathol. 2017. PMID: 27874193 Free PMC article. Review.
Cited by
-
A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis.Surg Case Rep. 2025;11(1):25-0181. doi: 10.70352/scrj.cr.25-0181. Epub 2025 Jul 16. Surg Case Rep. 2025. PMID: 40678018 Free PMC article.
References
-
- Hornick J. L., Yamamoto H. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours . Vol. 3. Lyon, France: International Agency for Research on Cancer; 2020. Inflammatory myofibroblastic tumour. (WHO classification of tumours series, 5th ed). https://tumourclassification.iarc.who.int/chapters/33 .
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous